Medlab Middle East: February 3-6 2025, at the Dubai World Trade Center
Qassay, a leader in digital health innovation, has confirmed its participation in the upcoming Medlab Dubai 2025. From February 3 to 6, attendees will have the opportunity to explore Qassay’s cutting-edge ecosystem at stand Z3.C56. The company will showcase its comprehensive digital health solutions, including an advanced digital reader, immunofluorescence assays, a user-friendly mobile app, and cloud software designed for seamless integration.
Empowering Diagnostics in a Growing Market
“Being present at Medlab Dubai offers an incredible opportunity to tap into the rapidly expanding Middle Eastern market, which has experienced significant growth in recent years,” stated Gorka Alapont, Business Development Manager at Qassay. Qassay’s solutions are transforming Point-of-Care (POC) diagnostics by providing fast, reliable, and cost-effective testing options. Their extensive catalog includes rapid tests for diabetes, hormones, cardiovascular health, inflammation, coagulation, bone health, and urine analysis.
About Medlab Dubai
Medlab Dubai is the premier medical laboratory exhibition in the Middle East, known for its substantial growth in exhibitors and visitors year over year. The 2025 edition promises to be the largest yet, featuring:
- 17,000 sqm of exhibition space
- 20,000 attendees
- More than 800 exhibitors
- Visitors from 180 countries
- 40 exhibiting countries
- 12 country pavilions
- $670 million in business generated in 2024
Don’t miss the chance to connect with Qassay at Medlab Dubai and explore innovative solutions shaping the future of diagnostics.
